Lyme Disease Diagnostics Market Analysis by Manufacturers, Regions, Types and Application to 2022

on

This Report Studies the Global Lyme Disease Diagnostics Market size, industry status and forecast, Latest Trends, Competition landscape and Growth Opportunity. This Research Report categorizes the Global Lyme Disease Diagnostics Industry by Companies, Region, Application, Type and end-use Industry.

The global Lyme Disease Diagnostics Market is expected to display rising growth in forthcoming years. The Lyme disease is an infectious disease caused by bacterial infections. It is caused by the bacterial species boreliaburgodorferi and spread forth by vector xodex scapular. Lyme disease is the most common vector-borne illness in United States and its incidence is increasing manifold. The Lyme disease is a tick-borne disease and ticks are carriers of this disease. Ticks bite is enough for the infected person to become a carrier of this disease.
The early signs are fever, rashes, depression and fatigue. If these signs are recognized at an early stage, antibiotics can help. But left untreated, the disease can affect central nervous system, heart and ruefully becomes a cause for death. Segmentation of Lyme disease diagnostics market includes diagnostic tests, emerging technologies and end-users. Some laboratories practice urine antigen tests, lymphocytic transformation test, immunofluorescent staining and PCR tests.
By emerging technologies, segmentation for Lyme Disease Diagnostic Industry includes molecular diagnostics, monoclonal antibodies, immunoasays, differential light scattering, liposomes, artificial intelligence, flow cytometry, information technology, gel microdroplets, chromatography and others. By geographical regions, segmentation for lyme disease diagnostics industry includes North America, Europe, Asia Pacific, MEA, and Latin America.
The end-user segment comprises hospitals, commercial labs/private labs, public health labs and physicians. There are numerous laboratories to check for tick bite and one of them is serological test, Serological test comprises Elisa and Western blot. The various other tests include urine antigen tests, lymphocytic transformation tests, immunofluorescent staining and PCR tests.
Routine blood tests samples are used to determine Lyme disease diagnostics and they are understandably good when blood tests help to rectify the problems associated with non-accurate serology based tests. North America accounts for major share in the Lyme disease diagnostics industry due to common occurrence of tick diseases in region. Europe and Asia markets go strong on the back of increasing patients suspected with Lyme disease diagnostics. The key players in lyme disease diagnostics market include Abbott Laboratories, Affeymetrics, Inc., Bio-Rad and Roche Diagnostics.   

Comments

Post a Comment